Vivantis Technologies Sdn Bhd

  • Increase font size
  • Default font size
  • Decrease font size
Home Latest news COVID-19 Testing on Saliva Sample using GF-1 Viral Nucleic Acid Extraction Kit and ViPrimePLUS 2019-nCoV Multiplex RT-qPCR Kit

COVID-19 Testing on Saliva Sample using GF-1 Viral Nucleic Acid Extraction Kit and ViPrimePLUS 2019-nCoV Multiplex RT-qPCR Kit

Mucus taken from nose or throat often causes coughing and sneezing, increase the possibility that healthcare workers become infected themselves. Collecting saliva samples may help in reducing the possibility of secondary infections, thus serve as a safer and better option.

Recently, R&D team from Vivantis Technologies has developed application note to suggest the use of GF-1 Viral Nucleic Acid Extraction Kit and ViPrimePLUS 2019-nCoV Multiplex RT-qPCR Kit to extract nucleic acid from saliva sample.

 

Download Application Note
 

We have 197 guests online

Subscribe To Our E-Newsletter







DOWNLOAD & RESOURCES

Brochure
MSDS
Video
Promotion

 

ADDITIONAL INFORMATION

ISO Certificate
RE Buffers Activity Chart

Reaching Us

Headquarters

Vivantis Technologies Sdn Bhd

Revongen Corporation Center,

Level 17, Top Glove Tower,

No. 16, Persiaran Setia Dagang,

Setia Alam, Seksyen U13,

40170 Shah Alam,

Selangor Darul Ehsan,

Malaysia.


Tel: +603-3359 1166

Fax: +603-3358 0303

 

 

ACCOLADES & ACCREDITATION

Acquaint Us

International Distribution/OEM services:

Email: international@vivantechnologies.com

WhatsApp: +6012 793 0184


Local Distribution/Sales Inquiries:

Email: info@vivantechnologies.com

WhatsApp: +6016 216 0492


Product Technical Support:

vivalab@vivantechnologies.com


General Enquiries:

info@vivantechnologies.com

 

SOCIAL MEDIA